Efficacy and safety of onabotulinumtoxinA in the treatment of medication overuse headache: a systematic review
PurposeMedication overuse headache (MOH) is a chronic headache caused by regular overuse of medications. OnabotulinumtoxinA (BoNTA) is used for preventive treatment of MOH. However, its efficacy and safety remain controversial.MethodsSeven online databases (Cochrane Library, Embase, Medline, PubMed,...
| 出版年: | Frontiers in Neurology |
|---|---|
| 主要な著者: | Hui Lang, Cheng Peng, Kongyuan Wu, Xiwen Chen, Xin Jiang, Li He, Ning Chen |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Frontiers Media S.A.
2024-09-01
|
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1453183/full |
類似資料
A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role
著者:: Licia Grazzi, 等
出版事項: (2023-01-01)
著者:: Licia Grazzi, 等
出版事項: (2023-01-01)
OnabotulinumtoxinA: Still the Present for Chronic Migraine
著者:: Carlo Baraldi, 等
出版事項: (2023-01-01)
著者:: Carlo Baraldi, 等
出版事項: (2023-01-01)
Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention
著者:: Sebastian Worsaae Dalby, 等
出版事項: (2024-02-01)
著者:: Sebastian Worsaae Dalby, 等
出版事項: (2024-02-01)
Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
著者:: Simona Guerzoni, 等
出版事項: (2017-11-01)
著者:: Simona Guerzoni, 等
出版事項: (2017-11-01)
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
著者:: Manjit Matharu, 等
出版事項: (2017-08-01)
著者:: Manjit Matharu, 等
出版事項: (2017-08-01)
Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
著者:: Simona Guerzoni, 等
出版事項: (2018-08-01)
著者:: Simona Guerzoni, 等
出版事項: (2018-08-01)
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
著者:: Ho-Tin Wong, 等
出版事項: (2020-10-01)
著者:: Ho-Tin Wong, 等
出版事項: (2020-10-01)
Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
著者:: Catherine Stark, 等
出版事項: (2019-07-01)
著者:: Catherine Stark, 等
出版事項: (2019-07-01)
OnabotulinumtoxinA for the treatment of headache: an updated review
著者:: Joseph H. Talbet, 等
出版事項: (2022-01-01)
著者:: Joseph H. Talbet, 等
出版事項: (2022-01-01)
Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
著者:: Amanda Hansson-Hedblom, 等
出版事項: (2020-08-01)
著者:: Amanda Hansson-Hedblom, 等
出版事項: (2020-08-01)
Evidencia y experiencia del uso de onabotulinumtoxinA en neuralgia del trigémino y cefaleas primarias distintas de la migraña crónica
著者:: S. Santos-Lasaosa, 等
出版事項: (2020-10-01)
著者:: S. Santos-Lasaosa, 等
出版事項: (2020-10-01)
The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability
著者:: Dilara Onan, 等
出版事項: (2023-12-01)
著者:: Dilara Onan, 等
出版事項: (2023-12-01)
Effectiveness and Safety of OnabotulinumtoxinA in Adolescent Patients with Chronic Migraine
著者:: Laura Gómez-Dabó, 等
出版事項: (2024-05-01)
著者:: Laura Gómez-Dabó, 等
出版事項: (2024-05-01)
Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
著者:: Chung-Cheng Wang, 等
出版事項: (2016-03-01)
著者:: Chung-Cheng Wang, 等
出版事項: (2016-03-01)
Results of treating Patients with Chronic Migraine with OnabotulinumtoxinA alone Versus Its Combination with Other Prophylactic Drugs
著者:: Saber Abdelrohman, 等
出版事項: (2022-04-01)
著者:: Saber Abdelrohman, 等
出版事項: (2022-04-01)
Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
著者:: Katarzyna Kępczyńska, 等
出版事項: (2022-09-01)
著者:: Katarzyna Kępczyńska, 等
出版事項: (2022-09-01)
A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
著者:: Srdjan Ljubisavljevic, 等
出版事項: (2023-10-01)
著者:: Srdjan Ljubisavljevic, 等
出版事項: (2023-10-01)
Medication-Overuse Headache: Update on Management
著者:: Prut Koonalintip, 等
出版事項: (2024-09-01)
著者:: Prut Koonalintip, 等
出版事項: (2024-09-01)
Comparative efficacy and safety of different pharmacological therapies to medication overuse headache: a network meta-analysis
著者:: Fanyi Kong, 等
出版事項: (2024-10-01)
著者:: Fanyi Kong, 等
出版事項: (2024-10-01)
Prediction models for identifying medication overuse or medication overuse headache in migraine patients: a systematic review
著者:: Teerapong Aramruang, 等
出版事項: (2024-10-01)
著者:: Teerapong Aramruang, 等
出版事項: (2024-10-01)
Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice
著者:: Kwang Jin Ko, 等
出版事項: (2023-05-01)
著者:: Kwang Jin Ko, 等
出版事項: (2023-05-01)
Medication-overuse headache: a widely recognized entity amidst ongoing debate
著者:: Nicolas Vandenbussche, 等
出版事項: (2018-07-01)
著者:: Nicolas Vandenbussche, 等
出版事項: (2018-07-01)
Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
著者:: Aubrey Manack Adams, 等
出版事項: (2023-08-01)
著者:: Aubrey Manack Adams, 等
出版事項: (2023-08-01)
Exploring Emotional Distress, Psychological Traits and Attitudes in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylaxis versus Withdrawal Treatment
著者:: Valeria Donisi, 等
出版事項: (2020-09-01)
著者:: Valeria Donisi, 等
出版事項: (2020-09-01)
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
著者:: Andrew M. Blumenfeld, 等
出版事項: (2018-02-01)
著者:: Andrew M. Blumenfeld, 等
出版事項: (2018-02-01)
Treatment with OnabotulinumtoxinA for Oromandibular Dystonia: A Systematic Review and Meta-Analysis
著者:: Kazuya Yoshida, 等
出版事項: (2024-12-01)
著者:: Kazuya Yoshida, 等
出版事項: (2024-12-01)
The Nursing Role in the Management of Medication Overuse Headache: Realities and Prospects
著者:: Luigi Alberto Pini, 等
出版事項: (2024-06-01)
著者:: Luigi Alberto Pini, 等
出版事項: (2024-06-01)
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
著者:: Marta Torres-Ferrus, 等
出版事項: (2020-07-01)
著者:: Marta Torres-Ferrus, 等
出版事項: (2020-07-01)
Urinary tract infections in the intradetrusor onabotulinumtoxinA population
著者:: Esme White, 等
出版事項: (2023-04-01)
著者:: Esme White, 等
出版事項: (2023-04-01)
Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication‐Overuse Headache
著者:: Gülcan Taşçatan, 等
出版事項: (2025-03-01)
著者:: Gülcan Taşçatan, 等
出版事項: (2025-03-01)
Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
著者:: Rachel Stading, 等
出版事項: (2024-12-01)
著者:: Rachel Stading, 等
出版事項: (2024-12-01)
Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
著者:: Dilara Onan, 等
出版事項: (2024-07-01)
著者:: Dilara Onan, 等
出版事項: (2024-07-01)
Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study
著者:: Shigeomi Iimura, 等
出版事項: (2023-09-01)
著者:: Shigeomi Iimura, 等
出版事項: (2023-09-01)
Medication overuse headache: a review of current evidence and management strategies
著者:: Yabets Tesfaye Kebede, 等
出版事項: (2023-08-01)
著者:: Yabets Tesfaye Kebede, 等
出版事項: (2023-08-01)
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
著者:: María Pilar Navarro-Pérez, 等
出版事項: (2024-06-01)
著者:: María Pilar Navarro-Pérez, 等
出版事項: (2024-06-01)
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
著者:: Hans-Christoph Diener, 等
出版事項: (2022-08-01)
著者:: Hans-Christoph Diener, 等
出版事項: (2022-08-01)
Medication-overuse headache. Retrospective comparison of preventive treatments
著者:: Abouch V. Krymchantowski, 等
著者:: Abouch V. Krymchantowski, 等
A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
著者:: Laura M. Tellechea, 等
出版事項: (2022-09-01)
著者:: Laura M. Tellechea, 等
出版事項: (2022-09-01)
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
著者:: Larry Charleston, 等
出版事項: (2023-08-01)
著者:: Larry Charleston, 等
出版事項: (2023-08-01)
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
著者:: Dilara Onan, 等
出版事項: (2022-12-01)
著者:: Dilara Onan, 等
出版事項: (2022-12-01)
類似資料
-
A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role
著者:: Licia Grazzi, 等
出版事項: (2023-01-01) -
OnabotulinumtoxinA: Still the Present for Chronic Migraine
著者:: Carlo Baraldi, 等
出版事項: (2023-01-01) -
Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention
著者:: Sebastian Worsaae Dalby, 等
出版事項: (2024-02-01) -
Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
著者:: Simona Guerzoni, 等
出版事項: (2017-11-01) -
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
著者:: Manjit Matharu, 等
出版事項: (2017-08-01)